Dr. Kelly graduated from Claremont McKenna College in 1982 and from Georgetown University School of Medicine in 1986. He completed neurosurgical training in 1993 at George Washington University Medical Center and then joined the UCLA Division of Neurosurgery. In 1998 he became director of the UCLA Pituitary Tumor and Neuroendocrine Program. He was Professor of Neurosurgery and Vice-Chief of the UCLA Division of Neurosurgery until 2007 when he joined John Wayne Cancer Institute and Saint John’s Health Center.
Dr. Kelly currently focuses his efforts on innovative treatments for patients with brain, pituitary and skull base tumors, providing fellowship training in minimally invasive neurosurgery, conducting clinical and translational research and providing patient education and community outreach.
- Daniel F. Kelly, MD
Director, Brain Tumor Center & Pituitary Disorders Program
Description
Dr. Kelly is a board-certified neurosurgeon and Director of the Brain Tumor Center & Pituitary Disorders Program at Saint John’s Health Center in Santa Monica, California. He is internationally recognized for his contributions in the field of minimally invasive surgery for brain, pituitary and skull base tumors. His research interests include refinements in endoscopic pituitary surgery and keyhole brain tumor removal, quality of life studies, post-operative and post-traumatic pituitary hormonal recovery, and brain tumor biomarkers. He has authored over 80 peer-reviewed publications and 20 book chapters. He is a member of the American Association of Neurological Surgeons, Congress of Neurological Surgeons and Pituitary Society. He is on the editorial boards of the journals Neurosurgery and World Neurosurgery. He is active in fostering neurosurgical training in developing countries and is Vice Chair of the Foundation for International Education in Neurological Surgery (FIENS).
Dr. Kelly graduated from Claremont McKenna College in 1982 and from Georgetown University School of Medicine in 1986. He completed neurosurgical training in 1993 at George Washington University Medical Center and then joined the UCLA Division of Neurosurgery. In 1998 he became director of the UCLA Pituitary Tumor and Neuroendocrine Program. He was Professor of Neurosurgery and Vice-Chief of the UCLA Division of Neurosurgery until 2007 when he joined John Wayne Cancer Institute and Saint John’s Health Center.
Dr. Kelly currently focuses his efforts on innovative treatments for patients with brain, pituitary and skull base tumors, providing fellowship training in minimally invasive neurosurgery, conducting clinical and translational research and providing patient education and community outreach.
